Precigen (PGEN) Total Non-Current Liabilities (2012 - 2026)

Precigen (PGEN) reported Total Non-Current Liabilities of $118.3 million for Q1 2026, up 290.24% year-over-year from $30.3 million in Q1 2025, and down 12.03% quarter-over-quarter from $134.5 million in Q4 2025.

Precigen (PGEN) Total Non-Current Liabilities (2012 - 2026) Analysis & Trends

Precigen (PGEN) has 15 years of Total Non-Current Liabilities data on file, last reported at $118.3 million in Q1 2026.

  • Total Non-Current Liabilities for Q1 2026 came in at $118.3 million, up 290.24% year-over-year; the trailing twelve-month figure through Mar 2026 was $118.3 million (up 290.24% YoY), and the FY2025 annual result was $134.5 million, up 71.21% from the prior year.
  • Total Non-Current Liabilities slipped to $118.3 million in Q1 2026 per PGEN's latest filing, from $134.5 million in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $261.7 million in Q1 2022 and troughed at $29.2 million in Q2 2025.
  • A 5-year average of $101.8 million and a median of $98.4 million in 2024 frame the typical range for Total Non-Current Liabilities.
  • The sharpest annual moves came in 2022 and 2026: Total Non-Current Liabilities increased 12.75% in 2022, then surged 290.24% in 2026.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $261.7 million in 2022, then sank by 87.56% to $32.5 million in 2023, then soared by 141.31% to $78.5 million in 2024, then surged by 71.21% to $134.5 million in 2025, then slipped by 12.03% to $118.3 million in 2026.
  • Business Quant data shows PGEN's Total Non-Current Liabilities at $118.3 million in Q1 2026, $134.5 million in Q4 2025, and $129.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - 42,980.09
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - 11.03 Mn
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 95.20 Mn
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - 644,700.00
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 5.87 Bn
9 Abivax 94.37 Bn 94.37 Bn - 64.76 Mn
10 Precigen 1.27 Bn 1.27 Bn 20.69 Mn 118.29 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 118.29 Mn
Dec 31, 2025 134.46 Mn
Sep 30, 2025 129.23 Mn
Jun 30, 2025 29.23 Mn
Mar 31, 2025 30.31 Mn
Dec 31, 2024 78.54 Mn
Dec 31, 2023 32.55 Mn
Mar 31, 2022 261.68 Mn
Dec 31, 2021 252.46 Mn
Sep 30, 2021 245.60 Mn
Jun 30, 2021 243.33 Mn
Mar 31, 2021 232.09 Mn
Dec 31, 2020 247.31 Mn
Sep 30, 2020 277.53 Mn
Jun 30, 2020 312.07 Mn
Dec 31, 2019 88,000.00
Sep 30, 2019 376.26 Mn
Jun 30, 2019 375.74 Mn
Mar 31, 2019 374.38 Mn
Dec 31, 2018 334.32 Mn